Abstract
We report the results of a double-blind study of dazoxiben in which treatment was continued for 3 weeks in patients with angiographically proven coronary artery disease who were receiving no other antiplatelet drugs.
MeSH terms
-
Adult
-
Angina Pectoris / drug therapy*
-
Angina Pectoris / physiopathology
-
Blood Pressure / drug effects
-
Double-Blind Method
-
Heart Rate / drug effects
-
Humans
-
Imidazoles / therapeutic use*
-
Male
-
Middle Aged
-
Oxidoreductases / antagonists & inhibitors*
-
Oxygen Consumption / drug effects
-
Physical Exertion / drug effects
-
Thromboxane-A Synthase / antagonists & inhibitors*
Substances
-
Imidazoles
-
dazoxiben
-
Oxidoreductases
-
Thromboxane-A Synthase